According to #TechSci Research Global cholesterol testing market is expected to grow at brisk rate during the forecast period owing reasons like surge in risk of cardiovascular diseases & obesity, surge in aging population and rising awareness and adoption of preventive healthcare. Visit : https://www.techsciresearch.com/report/cholesterol-testing-market/4663.html
#CholesterolTestingMarket #Marketresearch #MarketForecast #Marketfuture
2. 2
Scope of Report
Product of Interest (POI): Cholesterol Testing
Review Period
2015 – 2018
Base Year
2019
Estimated Year
2020
Forecast Period
2021 – 2025
Year Range
REGION
• Asia-Pacific
• Europe
• North America
• South America
• Middle East &
Africa
Global cholesterol testing market is expected to grow at a brisk rate during the forecast period
owing to surging risk of cardiovascular diseases & obesity, increase in aging population and rising
awareness about preventive healthcare. Additionally, increase in healthcare expenditure by
various governments around the globe is also driving cholesterol testing market. Furthermore,
rapid technological advancements in cholesterol testing and growing focus on developing new
products are the key factors contributing to the growth of cholesterol testing market globally.
Market Segmentation
END-PRODUCT
• Total cholesterol
• High-density
lipoprotein (HDL)
cholesterol
• Low-density
lipoprotein (LDL)
cholesterol
• Triglycerides
• Hospitals & Clinics
• Homecare
• Others
END-USER
TEST
• Lipid Panel
Test/Complete Lipid
Profile
• Apolipoprotein B Test
• Apolipoprotein A-1 Test
• Apoe Genotyping Test
• Apolipoprotein CII
• Others
INDICATION
• Atherosclerosis
• Diabetes
• Obesity
• Others
PRODUCT
• Test Strips
• Test Kits
• Without meter
• With meter
• Mail-in
AGE
• Before Puberty
• Puberty
• Adulthood
3. 3
Table of Contents
S. No. Contents Page No.
1. Product Overview
2. Research Methodology
3. Impact of COVID-19 on Global Cholesterol Testing Market
4. Executive Summary
5. Voice of Customer
6. Global Cholesterol Testing Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value & Volume
6.2. Market Share & Forecast
6.2.1. By Indication (Atherosclerosis, Diabetes, Obesity, Others)
6.2.2. By Product (Test Strips, Test Kits (Without meter, With meter, Mail-in))
6.2.3.
By End-Product (Total cholesterol, High-density lipoprotein (HDL) cholesterol, Low-
density lipoprotein (LDL) cholesterol, Triglycerides)
6.2.4.
By Test (Lipid Panel Test/Complete Lipid Profile, Apolipoprotein B Test, Apolipoprotein A-1 Test,
Apoe Genotyping Test, Apolipoprotein CII, Others)
6.2.5. By Age (Before Puberty, Puberty, Adulthood)
6.2.6. By End-User (Hospitals & Clinics, Homecare, Others)
6.2.7. By Company (2019)
6.2.8. By Region (Asia-Pacific, Europe, North America, South America and Middle East &
Africa)
6.3. Market Attractiveness Index
4. 4
Table of Contents
S. No. Contents Page No.
7. Asia-Pacific Cholesterol Testing Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value & Volume
7.2. Market Share & Forecast
7.2.1. By Indication
7.2.2. By Product
7.2.3. By End-Product
7.2.4. By Test
7.2.5. By Age
7.2.6. By End-User
7.2.7. By Country (China, India, Australia, Japan, South Korea)
7.3. Asia-Pacific: Country Analysis
7.3.1. China Cholesterol Testing Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value & Volume
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Indication
7.3.1.2.2. By Product
7.3.1.2.3. By End-Product
7.3.1.2.4. By Test
7.3.1.2.5. By Age
7.3.1.2.6. By End-User
5. 5
Table of Contents
S. No. Contents Page No.
7.3.2. India Cholesterol Testing Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value & Volume
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Indication
7.3.2.2.2. By Product
7.3.2.2.3. By End-Product
7.3.2.2.4 By Test
7.3.2.2.5. By Age
7.3.2.2.6. By End-User
7.3.3. Australia Cholesterol Testing Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value & Volume
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Indication
7.3.3.2.2. By Product
7.3.3.2.3. By End-Product
7.3.3.2.4. By Test
7.3.3.2.5. By Age
7.3.3.2.6. By End-User
6. 6
Table of Contents
S. No. Contents Page No.
7.3.4. Japan Cholesterol Testing Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value & Volume
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Indication
7.3.4.2.2. By Product
7.3.4.2.3. By End-Product
7.3.4.2.4 By Test
7.3.4.2.5. By Age
7.3.4.2.6. By End-User
7.3.5. Australia Cholesterol Testing Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value & Volume
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Indication
7.3.5.2.2. By Product
7.3.5.2.3. By End-Product
7.3.5.2.4. By Test
7.3.5.2.5. By Age
7.3.5.2.6. By End-User
7. 7
Table of Contents
S. No. Contents Page No.
8. Europe Cholesterol Testing Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value & Volume
8.2. Market Share & Forecast
8.2.1. By Indication
8.2.2. By Product
8.2.3. By End-Product
8.2.4. By Test
8.2.5. By Age
8.2.6. By End-User
8.2.7. By Country (France, Germany, United Kingdom, Italy, Spain)
8.3. Asia-Pacific: Country Analysis
8.3.1. France Cholesterol Testing Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value & Volume
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Indication
8.3.1.2.2. By Product
8.3.1.2.3. By End-Product
8.3.1.2.4. By Test
8.3.1.2.5. By Age
8.3.1.2.6. By End-User
8. 8
Table of Contents
S. No. Contents Page No.
8.3.2. Germany Cholesterol Testing Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value & Volume
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Indication
8.3.2.2.2. By Product
8.3.2.2.3. By End-Product
8.3.2.2.4 By Test
8.3.2.2.5. By Age
8.3.2.2.6. By End-User
8.3.3. United Kingdom Cholesterol Testing Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value & Volume
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Indication
8.3.3.2.2. By Product
8.3.3.2.3. By End-Product
8.3.3.2.4. By Test
8.3.3.2.5. By Age
8.3.3.2.6. By End-User
9. 9
Table of Contents
S. No. Contents Page No.
8.3.4. Italy Cholesterol Testing Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value & Volume
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Indication
8.3.4.2.2. By Product
8.3.4.2.3. By End-Product
8.3.4.2.4 By Test
8.3.4.2.5. By Age
8.3.4.2.6. By End-User
8.3.5. Spain Cholesterol Testing Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value & Volume
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Indication
8.3.5.2.2. By Product
8.3.5.2.3. By End-Product
8.3.5.2.4. By Test
8.3.5.2.5. By Age
8.3.5.2.6. By End-User
10. 10
Table of Contents
S. No. Contents Page No.
9. North America Cholesterol Testing Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value & Volume
9.2. Market Share & Forecast
9.2.1. By Indication
9.2.2. By Product
9.2.3. By End-Product
9.2.4. By Test
9.2.5. By Age
9.2.6. By End-User
9.2.7. By Country (United States, Mexico, Canada)
9.3. North America: Country Analysis
9.3.1. United States Cholesterol Testing Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value & Volume
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Indication
9.3.1.2.2. By Product
9.3.1.2.3. By End-Product
9.3.1.2.4. By Test
11. 11
Table of Contents
S. No. Contents Page No.
9.3.1.2.5. By Age
9.3.1.2.6. By End-User
9.3.2. Mexico Cholesterol Testing Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value & Volume
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Indication
9.3.2.2.2. By Product
9.3.2.2.3. By End-Product
9.3.2.2.4 By Test
9.3.2.2.5. By Age
9.3.2.2.6. By End-User
9.3.3. Canada Cholesterol Testing Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value & Volume
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Indication
9.3.3.2.2. By Product
9.3.3.2.3. By End-Product
9.3.3.2.4. By Test
9.3.3.2.5. By Age
9.3.3.2.6. By End-User
12. 12
Table of Contents
S. No. Contents Page No.
10. South America Cholesterol Testing Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value & Volume
10.2. Market Share & Forecast
10.2.1. By Indication
10.2.2. By Product
10.2.3. By End-Product
10.2.4. By Test
10.2.5. By Age
10.2.6. By End-User
10.2.7. By Country (Brazil, Argentina, Colombia)
10.3. South America: Country Analysis
10.3.1. Brazil Cholesterol Testing Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value & Volume
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Indication
10.3.1.2.2. By Product
10.3.1.2.3. By End-Product
10.3.1.2.4. By Test
13. 13
Table of Contents
S. No. Contents Page No.
10.3.1.2.5. By Age
10.3.1.2.6. By End-User
10.3.2. Argentina Cholesterol Testing Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value & Volume
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Indication
10.3.2.2.2. By Product
10.3.2.2.3. By End-Product
10.3.2.2.4 By Test
10.3.2.2.5. By Age
10.3.2.2.6. By End-User
10.3.3. Colombia Cholesterol Testing Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value & Volume
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Indication
10.3.3.2.2. By Product
10.3.3.2.3. By End-Product
10.3.3.2.4. By Test
10.3.3.2.5. By Age
10.3.3.2.6. By End-User
14. 14
Table of Contents
S. No. Contents Page No.
11. Middle East and Africa Cholesterol Testing Market Outlook
11.1. Market Size & Forecast
11.1.1. By Value & Volume
11.2. Market Share & Forecast
11.2.1. By Indication
11.2.2. By Product
11.2.3. By End-Product
11.2.4. By Test
11.2.5. By Age
11.2.6. By End-User
11.2.7. By Country (South Africa, Saudi Arabia, UAE, Kuwait)
11.3. Middle East and Africa: Country Analysis
11.3.1. South Africa Cholesterol Testing Market Outlook
11.3.1.1. Market Size & Forecast
11.3.1.1.1. By Value & Volume
11.3.1.2. Market Share & Forecast
11.3.1.2.1. By Indication
11.3.1.2.2. By Product
11.3.1.2.3. By End-Product
11.3.1.2.4. By Test
15. 15
Table of Contents
S. No. Contents Page No.
11.3.1.2.5. By Age
11.3.1.2.6. By End-User
11.3.2. Saudi Arabia Cholesterol Testing Market Outlook
11.3.2.1. Market Size & Forecast
11.3.2.1.1. By Value & Volume
11.3.2.2. Market Share & Forecast
11.3.2.2.1. By Indication
11.3.2.2.2. By Product
11.3.2.2.3. By End-Product
11.3.2.2.4 By Test
11.3.2.2.5. By Age
11.3.2.2.6. By End-User
11.3.3. UAE Cholesterol Testing Market Outlook
11.3.3.1. Market Size & Forecast
11.3.3.1.1. By Value & Volume
11.3.3.2. Market Share & Forecast
11.3.3.2.1. By Indication
11.3.3.2.2. By Product
11.3.3.2.3. By End-Product
11.3.3.2.4. By Test
11.3.3.2.5. By Age
11.3.3.2.6. By End-User
16. 16
Table of Contents
S. No. Contents Page No.
11.3.4. UAE Cholesterol Testing Market Outlook
11.3.4.1. Market Size & Forecast
11.3.4.1.1. By Value & Volume
11.3.4.2. Market Share & Forecast
11.3.4.2.1. By Indication
11.3.4.2.2. By Product
11.3.4.2.3. By End-Product
11.3.4.2.4. By Test
11.3.4.2.5. By Age
11.3.4.2.6. By End-User
12. Market Dynamics
12.1. Drivers
12.2. Challenges
13. Market Trends & Developments
14. Competitive Landscape
14.1. Competition Outlook
14.2. Players Profiled (Leading Companies)
15. Strategic Recommendations
16. About Us & Disclaimer
18. 18
Research Methodology
Identifying Key Opinion
Leaders
Questionnaire Design
In-depth Interviews
Data
Collection
Developing List
of Respondents
Formulating
Questionnaire
Market
Profiling
Data
Validation
Data
Analysis
In-depth secondary
research was conducted to
determine top players in
the global cholesterol
testing market, overall
market size and segmental
market size.
In order to conduct
industry experts’
interviews, TechSci
formulated a detailed
discussion guide.
List of industry
players and industry
specialists was
developed.
TechSci conducted
interviews with
industry experts and
industry players for
data collection and
verification.
Data obtained as a
result of primary
and secondary
research was
validated through
rigorous
triangulation.
The data was scrutinized
using MS-Excel, statistical
tools and internal
proprietary database to
obtain qualitative and
quantitative insights about
the global cholesterol
testing market.
Data
Collection
Data Filter
& Analysis
Research &
Intelligence
Actionable
Insights
Business
Solution
Primary Research Desk Research Company Analysis
Recent Developments
Market Changing
Aspects/Dynamics
Government Policies
Conclusion
Market Participants
Key Strengths
LinkedIn
TechSci Internal
Database
Factiva
Hoovers
Paid Sources
Company Websites
Company Annual
Reports
White Paper Study
Financial Reports
Investor
Presentations
Regulatory Body
Associations, etc.
Secondary
Research
Primary Research
19. 19
Research Methodology
Baseline Methodology
Our dedicated team of industry experts has monitored and analyzed various aspects of the global cholesterol testing market. The team
this market, while considering the the major influencing factors such as surging risk of cardiovascular diseases & obesity. The study
clients to take better decisions while planning their strategy to achieve sustainability in the global cholesterol testing market.
Methodology Followed for Calculation of Market Size:
• Market Size by Value: Market size, in terms of value, for the year 2019 was calculated based on information collected through
exhaustive secondary research and primary surveys, with various key opinion leaders/stakeholders, such as cholesterol testing
end-users, industry experts, and other industry participants.
• The team interviewed more than 15 – 20 cholesterol testing companies, 100 – 120 end-users, and 15 – 20 industry experts and other
cholesterol testing market to obtain the overall market size from 2015 to 2019, which was validated by the Delphi technique. Taking
size was averaged out, to arrive at the market size data during 2015-2019.
20. 20
Research Methodology
• Respondents were asked about the current and future market growth rates, market shares by product, by indication, by end-product, by test, by age, by end-user, by company and
by region. Removing the outlier responses, the geometric mean of growth estimates and provider wise revenue shares generated across various segments were considered, to
arrive at the final revenue shares. Revenue shares generated across various segments were further triangulated from other stakeholders.
Methodology Followed for Calculation of Market Shares:
Market share by product, by indication, by end-product, by test, by age, by end-user, by company and by region were calculated based on the responses received through primary
surveys with industry experts, in which the respondents were asked about the market shares or revenue generated from various segments of cholesterol testing markets. The final
shares were calculated by taking the geometric mean of the responses gathered from key opinion leaders after eliminating the outliers.
Methodology Followed for Forecasting:
• TechSci Research performed periodical checks on data collected through the surveys with logic checks and analyzed the survey results in SPSS/Tableau Software.
• Data triangulation techniques were applied to fill the gaps and to present a more meaningful picture of the market. To forecast global cholesterol testing market, TechSci Research
used various forecast techniques such as:
Moving Average
Time Series Analysis
Regression Analysis
Econometric and Judgmental Analysis
21. 21
Research Methodology
TechSci Research used its own forecast tool, which is based on the growth of various allied industries in respective regions. TechSci Research also used the impact analysis during
short, medium and long term period to estimate the demand and to reach accurate market numbers. It should be noted that the figures compiled are only for the organized market
including market share data. The currency used in the report is the United States Dollar (USD), with the market size indicated in USD million.
Partial List of Companies Interviewed Key Secondary Sources
• Abaxis, Inc.
• Abbott Laboratories
• Akers Biosciences, Inc.
• Beckman Coulter, Inc.
• Bio-Reference Laboratories
• Boston Heart Diagnostics Corporation
• Cell Biolabs, Inc
• Clinical Reference Laboratory, Inc.
• F. Hoffmann-La Roche Ltd
• Prima Lab SA
• PTS Diagnostics
• Quest Diagnostics
• Randox Laboratories
• Siemens Healthineers
• Sigma-Aldrich Corporation
• Spectra Laboratories
• SpectraCell Laboratories, Inc
• Thermo Fisher Scientific
• Unilabs
World Bank
TechSci Research Proprietary Database & Knowledge Repository
Company Annual Reports
Industry Magazines
Industry Reports
News Dailies
Credible Paid Databases
22. 22
Industry Brief
According to TechSci Research report, “Global Cholesterol Testing Market By Indication (Atherosclerosis, Diabetes, Obesity, Others), By Product (Test
Strips, Test Kits), By End-Product (Total cholesterol, High-density lipoprotein cholesterol, Low-density lipoprotein cholesterol, Triglycerides), By Test
(Lipid Panel Test, Apolipoprotein B Test, Others), By Age (Before Puberty, Puberty, Adulthood), By End-User (Hospitals & Clinics, Homecare, Others),
By Region, Forecast & Opportunities, 2025”, the global cholesterol testing market is expected to witness rapid growth during the forecast period. This
can be attributed to increasing incidence of cardiovascular diseases, obesity, technological advancements in cholesterol testing, rise in geriatric
population and growing awareness towards healthcare. Furthermore, increase in healthcare expenditure and rise in public awareness about various
cardiovascular diseases is anticipated to drive the market in the coming years. Moreover, high cholesterol has no symptoms; hence it requires a
complete cholesterol testing. Consumers are now aware of the risks associated with elevated levels of cholesterol and the increasing chances of heart
diseases due to it. Therefore, they prefer keeping a check on their cholesterol level. Also, physicians now a days are preferring for lab testing over self-
testing, besides growing awareness and adoption of preventive healthcare. Additionally, rise in public awareness about cardiovascular disease, health
risks associated with it, causes, treatment, and prevention is further anticipated to fuel the growth of cholesterol testing market. Moreover, ever evolving
home/self-testing market and emergence of noninvasive cholesterol testing methods are also expected to boost the global cholesterol testing market
across the globe. Furthermore, growing cases of thyroid disorders, especially among women and adults is also fueling the cholesterol testing market as
hypothyroidism causes disruption of lipid metabolism and requires cholesterol check. However, the global cholesterol testing market might also face
some hindrance in its growth. Swift growth in self-testing devices and emergence of noninvasive cholesterol testing approaches might prove as a threat
to the overall growth of cholesterol testing market.
The global cholesterol testing market is segmented based on indication, product, end product, test, age, end-user, and region. Based on product, the
market is segmented into test strips, and test kits. The test kits segment is further divided into without meter, with meter and mail-in. Among these, test
kits segment is anticipated to hold largest market share in terms of revenue during the forecast years as they are the most convenient and effective way
to test cholesterol levels and allow the monitoring of cholesterol without visiting the doctor and give test results in minutes. Based on test, the global
cholesterol testing market is segmented into Lipid Panel Test/Complete Lipid Profile, Apolipoprotein B Test, Apolipoprotein A-1 Test, Apoe Genotyping
Test, Apolipoprotein CII and others. Lipid panel test or complete lipid profile is expected to dominate the market until 2025 owing to the fact that the
results of this test can identify certain genetic diseases and can determine approximate risks for cardiovascular disease, certain forms of pancreatitis,
and other diseases.
Major players operating in the global cholesterol testing market include Abaxis, Inc., Abbott Laboratories, Akers Biosciences, Inc., Beckman Coulter,
Inc., Bio-Reference Laboratories, Boston Heart Diagnostics Corporation, Cell Biolabs, Inc, Clinical Reference Laboratory, Inc., F. Hoffmann-La Roche
Ltd, Prima Lab SA, PTS Diagnostics, Quest Diagnostics, Randox Laboratories, Sekisui Diagnostics, LLC, Siemens Healthineers, Sigma-Aldrich
Corporation, Spectra Laboratories, SpectraCell Laboratories, Inc, Thermo Fisher Scientific, Unilabs and others. The companies are focusing on
development of new and advanced monitoring devices to overcome the challenges in existing testing devices and hence the global market for
cholesterol testing is highly competitive.
“Emerging economies like China and India are serving as evolving markets for cholesterol testing companies due to the prevalence of poor dietary
habits and lifestyle patterns in these two nations. Additionally, the key market players are gaining cooperation from international bodies and local
government agencies with an aim to provide quality diagnostic testing services across the world. This is anticipated to further boost the cholesterol
testing market in the coming years. Also, medicare and medical benefits provided by organisations to their employees would also help fuel the overall
growth of the market.,” said Mr. Karan Chechi, Research Director with TechSci Research, a research based global management consulting firm.
24. 24
Report Ordering
Report Name: GLOBAL CHOLESTEROL TESTING MARKET
FORECAST & OPPORTUNITIES
2015 – 2025
To View Sample OR Purchase Report
License Type Price
Single User License $4450
Multi-User License $5450
Custom Research License $9450
25. About Us & Disclaimer
TechSci Research is a global market research and consulting company with offices in the US, UK and India. TechSci Research provides market research reports in
number of areas to organizations. The company uses innovative business Modes that focus on improving productivity, while ensuring creation of high-quality
of both industry-specific and macroeconomic variables on a state-by-state basis to produce a unique ‘bottom-up’ Mode of a country, regional and global industry
activity and industry trends, the result is a uniquely rich evaluation of the opportunities available in the market.
Related Reports
• Global Self-monitoring Blood Glucose Market By Type (Type 1, Type 2, Hyperglycemia ,Hypoglycemia), By Frequency (One, Four, Others), By
Product (Glucometer, Software, Test Strips, Lancet), By End-User (Hospital, Personal Care), By Region, Forecast & Opportunities, 2025
• Global Infectious Disease Testing Market By Product & Service (Assays, Kits, & Reagents; Instruments; Services & Software), By Technology
(Immunodiagnostics, Clinical Microbiology, Polymerase Chain Reaction, Others), By Disease (Hepatitis, HIV, HAIS, HPV, TB, Influenza, Glandular
fever, Coronavirus, Others), By end-user (Hospital/Clinical Laboratories, Reference Laboratories, Physician Offices, Academic/Research Institutes,
Other), By Region, Forecast & Opportunities, 2025
The contents of this report are based on information generally available to the public from sources believed to be reliable. No representation is made that it is timely,
accurate or complete. TechSci Research has taken due care and caution in compilation of data as this has been obtained from various sources including which it
considers reliable and firsthand. However, TechSci Research does not guarantee the accuracy, adequacy or completeness of any information and it is not responsible
for any errors or omissions or for the results obtained from the use of such information and especially states that it has no financial liability whatsoever to the
subscribers / users of this report. The information herein, together with all estimates and forecasts, can change without notice. All the figures provided in this
document are indicative of relative market size and are strictly for client’s internal consumption. Usage of the same for purpose other than internal will require prior
approval of TechSci Research.
TechSci Research – North America
708 Third Avenue, Manhattan,
New York, United States
Tel: +1- 646- 360- 1656
Email: sales@techsciresearch.com
www.techsciresearch.com
Disclaimer
TechSci Research – Europe
54, Old brook, Bretton,
Peterborough,
United Kingdom
Email: sales@techsciresearch.com
www.techsciresearch.com
TechSci Research – Asia-Pacific
B – 44, Sector – 57, Noida, National Capital
Region, U.P. - India
Tel: +91-120-4523900
Email: sales@techsciresearch.com
www.techsciresearch.com